Schoolgirl's death was not due to HPV vaccine

 

The 14-year-old girl who died after receiving the HPV vaccine on Monday was suffering from a serious underlying health condition.

Cervarix cervical cancer vaccination (Photograph: DR P. MARAZZI/SPL)

Cervarix cervical cancer vaccination (Photograph: DR P. MARAZZI/SPL)

Preliminary results of a post mortem examination on the Coventry schoolgirl showed there was no causal link between her death and the vaccine.

Concerns about the safety of the Cervarix jab led to the batch being quarantined and it has now been recalled by manufacturer GSK for further investigation.

Dr Caron Grainger, joint director of public health for NHS Coventry and Coventry City Council said: ‘The preliminary post mortem results have revealed a rare serious underlying medical condition which was likely to have caused death.

‘We are awaiting further test results which will take some time. However indications are that it was most unlikely that the HPV vaccination was the cause of death.'

Nine other pupils at the same school had reported feeling unwell following HPV vaccination that day but the symptoms were mild and in line with the side effects usually reported, said NHS Coventry.

The Medicines and Healthcare products Regulatory Agency said the recall of the batch was being voluntarily carried out by GSK as a precautionary measure while further investigations took place.

An agency spokesman said: ‘Healthcare professionals administering the vaccine are being asked to return any unused stock of this batch to GSK. The national HPV vaccination programme will continue as there are no supply issues associated with Cervarix and new stock is readily available.

‘More than 1.4 million doses of HPV vaccine have now been administered in the United Kingdom and there have only been a little more than two thousand reports of adverse reactions.

'This is what we would normally expect from any vaccination programme and the reports of reaction to Cervarix have been relatively mild, including fever, headache, fatigue, muscle pain, nausea, vomiting and diarrhoea.'

X

You must log in to add to your Storage Folder

All Comments

mf bell - 30 September 2009

it begs the following questions:

1. that without the vaccine she may have continued her normal life without incident, with her underlying condition undiscovered and not an issue

2. How many more undiscovered underlying conditions may be present in an otherwise healthy population who may be susceptible to the same risks as this poor teenager?

 

john oakley - 30 September 2009

1. Are we to be told what the "rare serious underlying medical condition" is called?

2. The stated "average" incidence of anaphylaxis associated with vaccines is 1 per 2 million vaccine administrations, although it is stated to occur more commonly with Cervarix.

Are the Schools Services properly trained and fully equipped to deal with the cases of anaphylaxis which will occur sooner or later?

 

Sara - 30 September 2009

We have received a number of calls from parents and schools and we need to be able to tell them what the ''rare serious underlying' condition is to restore confidence.

 
Emilie Reymond

Emilie Reymond - 01 October 2009

Hi Sara - we've published an update on this story - please visit http://www.healthcarerepublic.com/news/942531/Malignant-tumour-caused-HPV-jab-girls-death

 

Abdulrazak Gundkalli - 01 October 2009

in the interest of all involved it would be better to know all rare medical conditions to be listed in warning and contraindications for vaccine concerned.

 

Comments

To post comments please log in here

MIMS Drug Search

Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.

Bulletins

Select the bulletins you are interested in, enter your email address and click the button below.

Preview
Preview
Preview
Preview
Preview
Preview
Preview
Preview
Preview
 

Directory